RxSight
Healthcare · 388 employees
RxSight® is an ophthalmic medical technology corporation headquartered in Aliso Viejo, California that has commercialized the world’s first and only adjustable intraocular lens (IOL) that is customized after cataract surgery. The company’s mission is to revolutionize the premium cataract surgery experience by allowing surgeons to partner with their patients to achieve optimized results for every u
Funding history
- Funding Round — $50.0M — Apr 2017
- Funding Round — $38.7M — Mar 2017
Recent signals
- Jan 11, 2026: RxSight Appoints Mark Wilterding as Chief Financial Officer
- Dec 23, 2025: SEC 8-K (5.02): On December 23, 2025, RxSight, Inc. entered into a Transition Agreement and Consulting Agreement with Shelley Thunen, who is stepping down as the Chief Financial Officer. The Transition Agreement outlines the terms under which Ms. Thunen will assist the company during the transition period following her departure. The consulting agreement will commence as of her employment separation date, allowing her to provide certain transition services to the company. The agreements are significant as they ensure a smooth transition of financial leadership within the company, which may impact the company's operational continuity during this leadership change.
- Apr 03, 2017: Raised $50.0M
- Mar 08, 2017: Raised $38.7M
See plans & pricing → Track RxSight’s funding, hiring, and signals — with verified contacts — on Fundz.